Drug Infusion System Market Research Report – Forecast to 2030

Drug Infusion System Market Research Report, by Product Type (Elastomeric Infusion System, Disposable Infusion System), by Application (Oncology/Chemotherapy), Mode of Administration (Intravenous), End-User (Hospitals) - Forecast Till 2030

ID: MRFR/MED/4748-HCR | 100 Pages | Published By Kinjoll Dey on March 2023         

Drug Infusion System Market Scenario

The Drug Infusion System Market is expected to reach USD 11.97 Billion by 2030 at 7.20% CAGR during the forecast period 2022-2030. The drug infusion systems are medical devices that allow infusion of drugs like antibiotics, chemotherapy drugs, insulin, painkillers and others in a controlled manner.

The increase in the prevalence of chronic diseases like cardiovascular disease, stroke, cancer, type 2 diabetes, obesity, and arthritis drives the market growth. According to the World Health Organization 2018, 70% of deaths occur due to non-communicable diseases like diabetes, heart disease, stroke, chronic lung disease and heart disease, stroke, cancer worldwide. Also, the rising geriatric population, adoption of technologically advanced devices and rising healthcare spending provide favorable backgrounds for the market to grow. Also, due to their easy to use, portability, ergonomic design, and visual monitoring features favor the potential growth of the market.

However, factors such as the high cost of drug infusion system, shortage of skilled labor and stringent government rules and regulations for product approval are expected to restrict the market growth during the forecast period.

Research Methodology

Market Research Future research is conducted by industry experts who offer insights into industry structure, market segmentation, assessment, Competitive Landscape (CL), penetration, as well as on emerging trends. Besides primary interviews (~ 80%) and secondary research (~ 20%), their analysis is based on their years of professional expertise in respective industries. Our analysts also predict where the market will be headed in the next five to ten years, by analyzing historical trends and current market positions. Furthermore, the varying trends of segments and categories geographically presented are studied and are estimated based on the primary and secondary research.

  • Primary Research

Extensive primary research was conducted to gain a deeper insight into the market and the industry performance. In this particular report, we have conducted primary surveys (interviews) with key level executives (VPs, CEOs, Marketing Directors, Business Development Managers, and many more) of the major players who are active in the market. In addition to analyzing the current and historical trends, our analysts predict where the market is headed, over the next five to ten years.

  • Secondary Research

Secondary research was mainly used to collect and identify information useful for the extensive, technical, market-oriented, and commercial study of the drug infusion system market. It was also used to obtain key information about major players, market classification, and segmentation according to industry trends, geographical markets, and developments related to the market and perspectives. For this study, analysts have gathered information from various credible sources, such as annual reports, SEC filings, journals, white papers, corporate presentations, company websites, international organization of chemical manufacturers, some paid databases, and many others.


The Drug infusion system market is segmented on the basis of product type, mode of administration, application, and end-user. The drug infusion system market, by product type, is sub-segmented into elastomeric infusion system, disposable infusion system, syringe infusion system, peristaltic pump, multi-channel pump, Patient-Controlled Analgesia (PCA) pump, insulin pump, and implantable infusion system. On the basis of application, the market is categorized into oncology/chemotherapy, diabetes, analgesia, nutrition, hematology, pediatrics, and others. The mode of administration is further sub-segmented into intravenous, subcutaneous, arterial, epidural, and others. On the basis of end-user, the market is segmented into hospitals, ambulatory surgical centers, diagnostic centers, and others.

On the basis of region, the drug infusion system market is segmented into the Americas, Europe, Asia Pacific, and the Middle East and Africa.

The Americas is sub-segmented into North America and South America. The North American region is further segmented into the US and Canada. The European region is divided into two, namely, Western Europe and Eastern Europe. Western Europe is further classified into Germany, Italy, France, the UK, Spain, and the rest of Western Europe. The Asia Pacific region is sub-segmented into Japan, China, India, Australia, the Republic of Korea, and the rest of Asia Pacific. The Middle Eastern and African region is sub-segmented into the United Arab Emirates, Saudi Arabia, Oman, Kuwait, Qatar, and the rest of the Middle East and Africa.

Drug infusion system Market, by Key Players

  • Medtronic

  • arcomed AG

  • Braun Melsungen AG

  • Baxter

  • Becton Dickinson and Company

  • Debiotech S.A.

  • Fresenius SE & Co. KGaA

  • Halyard Health, Inc

  • ICU Medical Inc

  • IRadimed Corporation

  • Insulet Corporation

  • Terumo Corporation

  • Smiths Group plc

  • Tandem Diabetes Care


  • Others

Regional Market Summary

The drug infusion system market is dominated by North America owing to the rising chronic diseases region. According to the Heart Disease and Stroke Statistics 2018, 836,546 deaths in the US were due to cardiovascular disease. Such a high incidence rate of cardiovascular diseases drives the market growth in this region

It is estimated that Europe stood second in the Drug infusion system market. Increasing prevalence of chronic disease, rising health care expenditure and health care activities are driving the growth of this market in Europe. As per the Organization for Economic Co-operation and Development (OECD) in 2016, 550,000 working‑age people died due to chronic disease in European Union countries.  Such a high prevalence of chronic disease is expected to boost the market in this region.

Asia Pacific was projected to be the fastest growing region for the Drug infusion system market.

Drug infusion systems are frequently used for delivering insulin into patient’s body. Growing prevalence of diabetes influences the market in this region. According to the Asian Diabetes Prevention Initiative, 60% of the world’s diabetic population lives in Asia. This propels the growth of the market in this region.

The Middle East and Africa holds the least share in the global Drug infusion system market due to the presence of stringent government policies and poor economies. However, increasing investment by private market players in this region can boost the market growth. 

Market Segmentation and Key Market Players

Drug infusion system Market, by Product Type

  • Elastomeric infusion system

  • Disposable infusion system

  • Syringe infusion system

  • Peristaltic pump

  • Multi-channel pump

  • Patient-controlled analgesia (PCA) pump

  • Insulin pump

  • Implantable infusion system

Drug infusion system Market, by Application

  • Oncology/Chemotherapy

  • Diabetes

  • Analgesia

  • Nutrition

  • Hematology

  • Pediatrics

  • Others

Drug infusion system Market, by Mode of administration

  • Intravenous

  • Subcutaneous

  • Arterial

  • Epidural

  • Others

Drug infusion system Market, by End-user

  • Hospitals

  • Ambulatory Surgical Centers

  • Diagnostic centers

  • Others

Drug infusion system Market, by Region

  • The Americas

  • Europe

  • Asia Pacific

  • The Middle East & Africa

Intended Audience

  • Pharmaceutical companies

  • Biotechnological institutes

  • Government and private laboratories

  • Research and Development (R&D) companies

  • Medical research laboratories

  • Market research and consulting service providers

Report Scope:

Report Attribute/Metric Details
  Market Size   USD 11.97 Billion
  CAGR   7.20%
  Base Year   2021
  Forecast Period   2022-2030
  Historical Data   2018
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Product Type, Mode of Administration, Application, and End-user
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   Medtronic, arcomed AG, Braun Melsungen AG, Baxter, Becton Dickinson and Company, Debiotech S.A., Fresenius SE & Co. KGaA, Halyard Health Inc, ICU Medical Inc, IRadimed Corporation, Insulet Corporation, Terumo Corporation, Smiths Group plc, Tandem Diabetes Care, MOOG INC., Others
  Key Market Opportunities   New product launches and R&D Amongst major key Players
  Key Market Drivers

  • Rising geriatric population
  • Adoption of technologically advanced devices
  • Rising healthcare spending provide favorable backgrounds

  • Speak to Analyst Ask for Customization

    Frequently Asked Questions (FAQ) :

    Drug infusion system market has a high cost of the procedure, strict government rules, lack of product approval, and lack of skilled labor as major deterrents.

    The system has segments like disposable infusion system, elastomeric infusion system, multi-channel pump, syringe infusion system, peristaltic pump, insulin pump, Patient-Controlled Analgesia (PCA) pump, and implantable infusion system.

    The applications are diabetes, oncology/chemotherapy, nutrition, hematology, analgesia, pediatrics, and others.

    The segments are intravenous, subcutaneous, arterial, epidural, and others.

    The end users are diagnostic centers, ambulatory surgical centers, hospitals, and others.